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S*. Louis. Misroari 
The wtcomr of medical treatrnerd of dilated cardiamy- 
o&w in infants and children was reviewed to dwtm o 
p~&iftiw index for rptition of ptknts likely 10 be& 
Iron urdtac tmwptantattan. The ctinkat Rndtngs, tabcra- 
tory bwestigations, treatnwnta d outcome of 10 patients 
(Group I) <2 yeara of as at prewdntiw and 12 patknts 
(Group 2) >2 yrsn cd age at reset were mmpared. of 20 
Grwp I patkmts, 5 (25%) dkd. Araitatdo autopsie (kmr 
ptk!da *lJwd rndacardtt tihmetastmk. Of 15 rurvi- 
rora, 10 ahwed imprwement in cardiac status and 5 
remained unchnnged. Ninety-three perrent of surviwm 
had dlkkd cardtomyopathy conskterd with endorardiat 
ttbmet@tMk by an@ardtography. AU 12 Group 2 pa- 
tknts dkd. lo addition to age at prrsmtatton nd pmr 
mdcnme. Group 2 dimred Imm Group I in having B higher 
incidence of other landty mmtberj with mrdiamyopathy, 
rnon ii@tamt rhythm dii~urbanee at presentation md a 
more rapid o,w-ae to dead,. Rbk Tacten of paor wteome tn 
both gmmups included prdstmt mrdkmegrdy pod the de- 
velepment of sigr&ranl arrhythmt@ by Holtrr rkctrww 
dttqaphtt nlmitting. 
Cardiac fransllkntauo” k rcmamendrd (01 children 
with d”ated rardianyoprtby prsentiog tier sge 2 years 
rho nurvke t m&h. These patients C2 years dd at 
prwntation whose mnditloo baF not improved after 1 year 
and whr, have perdstcnt rardhnme@y or rwnp& ve”trk- 
ukr rarhythmim may at.w hewit lrmn transptantation. 
Dilated cardiomyopathy in children is characterized by an 
unobslructed. dilated and poorly contracting left ventricle. 
and is usually associated with congestive heart failure (I-4). 
Microscopic examination of the myocardium shows 
myoqte iypertrophy. interstitial fibrosis and, in some pa- 
tients, thickening of the tefi ventricular endocardium (endo- 
cardial fibroekrtosis). Dilated cardiomyopathy remains an 
enigma etiologically and a difficult and challenging problem 
therapeutically. Although approximately 500/c of patients 
who hwe dilated cardiomyopathy associated with endocar- 
dial tibroelastosis will respond iavorably to conventional 
antico ~gestive measures. most others follow a relendcss 
course to death (IA). The advent of cardiac transplantation 
now otfers hope of prolonged wrvwal in this later group 
(5-7). The purpose of this report is to reww our experience 
with patients who have been diagnosed as having dilated 
cardiomyopathy, in an elIor to develop a predictive index to 
select those patients who might respond to medical manage- 
ment and those who might be suitable candidates for cardiac 
transplantation. 
Methods 
Patknt selection. The records oi patients seen a1 Chit- 
dren‘s Hospital at Washington University Medical Center 
from January 1975 to July 1985 with the diagnosis of dilated 
cardiomyopathy were reviewed. Patients presenting with 
cardiomcgaly. often raw&ted with congestive heart failure, 
and evidence of an unobstructed, dilated. poorly contracting 
left ventricle were identified and labeled as having dilawi 
cardiomyopathy. Patients with congenital heart defects. 
vatvutar heart disease. chronic arrhythmia. reslrictive or 
hypenrophic cardiomyopathy. or both, acute myocarditis 
and heart disease as a result of renal. endocrine, metabolic 
or collagen vascular disorders were not included. In an cUon 
to identify previous infectious viral myocardhis, cultures 
and serologic adies were performed on all patients. Sero- 
logic studies included acute and convalescent antibody titels 
for coxsackievirus. adenovirus and echovirus. 
Study patients. Thirty-two patients met our criteria for a 
diamobis of dilated cardiomvouathv and were classified into 
gm& according to age. Groub I &mprised 20 patients 52 
years of age. The remaining 12 patients >2 years of age at 
presentation were included in Group 2. The diagnosis was 
established in IO patients by autopsy. The presumptive 
diagnosis was made by cardiac catheterization and angiocar- 
diography in IS patients and by clinical examination and 
echocardiography in 4. 
Follow.up. Follow-up information was obtained from 
clinic records. The parents of the% palients not seen by July 
IY85. were conttacted by telephone for an interview. The 
paticms wcrc followed up at regular intervals as determined 
by their clinical st~s. Two patients in Group I could not he 
located for recent follow-up. 
Statisiicnl methods. Cumulative survival was determined 
using life table methods. Comparison of the survival curves 
was carried out using unpaired one-tail Student I testing by 
usinc standard error of the life table intervals as described hv 
Greenwood (8). Comparison of data from noninvasive anh 
invasive studier was performed using the Student I test for 
unpaired data. 
RWlltS 
Clinical findings. The presenting clinical features are 
summarized in Table I, The mean age at presentation for the 
20 patients in Group t was 9 months (range I day to I8 
months). Average follow-up was 4 years (range 0 to 14). The 
number 3f male patients was 8 (40%) of 20. An apical heari 
murmur consistent with mitral regurgitation was present in 8 
patients (40%); congestive heart failttrc was present in 14 
(70%). Other patients were evaluated for cardiomegaly by 
routine chest roentgenogram. The clinical profile revealed 
dvspnea and tachypnea in all patients. No family history of 
death from dilated cardiomyopathy was obtained in any 
patient. Chest roentgenogmms showed cardiac enlargement 
with a mean cardiothoracic ratio of 0.67 (range 0.59 to 0.81). 
The I2 parit-nrs in Gro!~p 2 1Tuble IB) prwntcd LII II 
nwun age uf IO ymrs ,r,,nge 5.5 IO 151. Average follow-up 
was 2 years (range 0 to 9). Of these patients, six t.W%) were 
male. Four patients presented with a murmur consistent with 
mitral insufficiency and three presented with svncooal eoi- 
s&s. Congeslive~ heart failure was slightly m&e p~eval~nl 
in this Group (IO 183%1 of 12) than in Group 1. In contrast 
with the younger group. a family history of death due lo 
dilated cardiomyopathy was recorded in 25% (3 of I2 fani- 
lies) of Group 2. The cardiothoracic ratio on chest roentgen- 
ogrem was 0.65 (range 0.54 to 0.76). 
Electrocardiographic (ECG) and Holler monitor findings. 
The initial ECG in I9 (95%) of the 20 patients in Group I 
WYC Raltening or inversion (9). Neither atrial nor ventricu- 
lar rhythm disturbances were found. The small number of 
patients in Group I undergoing Holler KG monitoring 
precluded analysis. In Group 2. ECG abnormalities were 
noted in all. The ECG showed left ventricular hypertrophy 
withTwaveRatteningorinversionin9ofthe I2 patients: lefi 
axis deviation was seen in 5 and intravcntricular conduction 
delay in 4 patients. In addition, 3 of the I2 had ventricular 
ectopic activity and 3 had atrial fibrillation or flutter. Nine of 
the I2 Gmup 2 patients underwent ambulatory Holter mon- 
itoring. Seven of these nine patients showed significant 
ventricular arrhythmias (Lawn class ~3). including one 
patien! who z!sr h-6 an atrial arrhythmia; one patient 
manifested only right bundle branch h&k and one had an 
enlirely normal Holler recording. 
Echocardiographic findings. M-mode echocardiograms 
were obtained at presentation using standard techniques in 
30 (90%) of the 32 patients. The initial mean left ventricular 
end-diastolic dimension was >I.4 times the nomtal mean 
value for age and body surface area in all patienls in both 
erouos ,101. The left ventricular end-diastolic dimension was 
&nificantly different ,p < 0.05) comparing Group I (4.1 f 
0.9cm) withGmup2(5.5 + 0.9cm).TheseditTerencesinleft 
ventricular dimension are a reflection of age and size. There 
was no significant difference in echocardiographic fractional 
shortening (0.23 * 0.08 wsus 0.19 t 0.12. p = NS) or 
velocity ofcircumferential fiber shortening (I.2 t 0.4 versus 
0.9 ? 0.4. p = NS) comparing Group I with Group 2. Mural 
ventricular thrombi were visualized in only one natient in 
Group 2. and in no patients in Group I. 
Invasive evslustion. Cardiac catheterization was per- 
formed in 14 of the 20 patients in Group I within 2 months of 
presentation. Mean right atrial pressure (al0 mm Hg) was 
elevated in 4 of the I4 patients. Pulmonary capillary wedge 
pressure was elevated ,915 mm Hg) in five of six patients in 
whom it was measured (mean 20 mm Hg1. Left ventricular 
end-diastolic pressure was elevated ,alSmm Hg) in I2 01 I3 
(mean 21 mm Hg). A decreased cardiac index (52.5 liters/ 
min per m’) was present in 6 of I4 patients. and the systemic 
~a~cttlar resistance index (>1,4W dynesacm-‘1 was ele- 
vated in IO of 14. 
Cardiac cafhrrrrizotim nm perfirmed in 8 of rhr 12 
plien1s it, Group 2. Most of these patients had elevated right 
atrial (four of seven). pulmonary wedge (seven of eight) and 
left ventricular end-diastolic pressures (five of six). Cardinc 
index was low in two of seven of these patients. and the 
syslemic vascular resistance was elevated in three of these 
seven. There was no significant difference between Group I 
and Group 2 with regard to mean pulmonary wedge pressure 
(24 + 4 vers”s 21 + 12 mm Hg. p = NS), let, ventricular 
end-diastolic pressure (22 f I I versus 25 + I2 mm Hp. p = 
NS). cardiac index (3.2 c I.0 versus 3.5 + 1.0 literslmin per 
ml, p = NSJ or systemic vascular resistance (1.747 i- 744 






ciency was present. 
Angincnrdiography R’LIS performed in 14 patients in 
Group I and 8 paliwrts in Group 2. All patients had norn~al 
coronary arwies. In Grnup I, biplane a giocardiography 
Treatment. Ail mtients were treated with digoxin. A 
demonstrated an enlarged. thick-walled left ventricle, mini- 
mal changes in systolic and diastolic volumes and a smooth 
endocardium in II of 14 patients. Markedly decreased 
function wns found in 3 of the 14. Thew findings were 
suggestive of endocardial fibraelastasis. Angiocardiography 
demonstrated global ventricular dilation and marked systolic 
dysfunction in all patients in Group 2. No significant mitml 
mgurgitation (grade 2+ or more) wes identified in either 
group even though B murmur consistent with mitral insuffi- 
catheterization, and dted ofprogressive heart failure within 6 
months of onset. 
Oulemne. The results of life table analysis for Groups I 
and 2 ore shown in Figure I. Statistical anelysis showed a 
significantly greeter survival in Group I when compared with 
Group 2 at all intervals of follow-up, (p < 0.05). 
A torrrl of I5 (75%) o.f fhr 20 pofienrs in Group I Wnger 
gt groupj survived and showed clinical improvement or 
stabilization during a mean follow-up period of3.9 years. In 
IO patients, the heart size re:umed lo normal cm ches: 
roentgenogrem Among ihene IIJ patients, the eleclrocardio- 
gram returned to normal in five and in four others showed 
only minimal residual T wave Battening. Clinical status 
improved with anticongestive therapy. Cardiomegaly re- 
solved gradually over a period of months lo years. Serial 
echocardiographic measurements in the patients with im- 
proved status showed a decrease in left ventricular end- 
diastolic dimension. Treatment with dig&n and diuretics 
was discontinued in these IO patients and they remained 
asymptomatic. Five of the I5 surviving patients remained in 
stable condition and showed a chronically dilated heart. 
They are functionally in New York Heart Association class 
II. These patients required treatment throughout the study 
period. although two showed a decrease in eardiolhoracic 
ratio. The original angiographic studies in survivors in this 
age group were compatible with endocardial Pbroelastosis in 
13% of the patients. 
years (range 0 to 12). Three patients died suddenly, and two 
died of intractable congestive heart failure. Necmw in four 
The cumulative morra/ily rare in Group I was 25% (5 of 
20). The mean interval from presentation to death was 3.2 
combination of hydrochlorothiazide and spironolsctone was 
used for diuresis in all patients. Most recently treated 
patients received afterload reduction with various agents 
ihydrelarine, pnzosin or captoptil) based on the results of 
Swan-Ganz catheterization. Atrird fibrillation and significant 
ventricular arrhythmia were treated with antiarrhylhmic 
medications ard efficacy of therapy wes assessed by serial 
ECG Halter or bedside monitor. Clinical response was good 
but did not appear to change prognosis. Supponive therapy 
with oxypn. supplemental nutrition and antibiotics for 
intermittent infections was also used. All patients were 
maintained on this therapy unless clinical and laboratory 
improvement was documented. In that case. the digoxin and 
diuretic theraov was discontinued. 
of the five patients re&led endocardial fibmel&&. This 
confirmed the presumptive diagnosis in these patier&, which 
was initially made by cardiac catheterization and an&car- 
diography. 
The DUIE~~P ofppariennrs in Group 2 (older age groupl was 
markedly differentfrom that ofpoliennls in Group 1. None of 
the older patients showed improvement. Rather, cumulative 
mortality in Group 2 was lOi% with a mean interval of 2 
years (range 2 weeks to 9 years) between age at onset of 
symptoms and death. Five of the 12 patients died within 6 
monlhsofpresenletionand83(1ltof 12)weredead wilhin2.5 
years of presentation. Four deaths were sudden, and eight 
patients died because of intractable congestive heart failure. 
Ventricular hiorsv. auto~sv or cardiac aneiocardioarauhv 
Thrombo&bolic ewnrs necessitated treatment with oral 
. 
excluded endacardial fibrcelastosis in I I of the I2 p&ents. 
warfxin (Coumadin) or aspirin in three patients. No specific Role of cardiac arrhythmias. Atrial and ~enlri~ular 
noninvasive or invasive variables identified this group et arrhythmias were found in patients in both groups who died. 
risk. Other pnticnts were not treated with these medications. Of the five patients in Group I who died. two had 24 hour 
Two patients in Group 2 were considered 8s candidates for ambulatory monitoring performed within 4 weeks of death. 
cardiac transplantation. The parents of one patient refused These Tao patients showed complex ventricular ectopic 
operalion: within 6 months, the patient developed increasing activity (Lawn class -23) and atrial fibrillation or flutter. Both 
pulmonary vascular resistance and thromboemboli. The died suddenly. Another patient who died without ambula- 
other ~atienl had pulmonary hypertension demonstrated by tory monitoring showed left posterior hemihlock on a slan- 
dard ECG. Of the 12 patients in Group 2 who died, IO were 
era1 patients had no&d rhythm on Holter monito>ng at 
studied by 24 h ambulatory monitoring. All showed signifi- 
cant ventricular arrhythmia before death. One patrent had 
presentation but developed ventricular arrhythmia before 
had a ventricular oacemaker olaced orevmusl~ because of 
sick sinus syndrome. Two patiknts of ihis group who did not 
underno ambulatorv ECG monitoriw rhowed left axis dew 
ation or intraventricular conduction~delay. No patient had 
sustained ventricular tachycardia (lastmg 230 s or associ- 
ated with syncope). 1 wo patients had nonsustained ventri- 
cular tachycardia P3 complexes but ~30 s; no syncope). 
Two patients treated for ventricular arrhythmia (proama- 
mide) died despite improvement on Holler monitoring. Sev- 
Recent \tud!es (Ii of children (2 years old at time of 
dmgnoris) wth dilated cardiomyopathy suggest rhar survival 
is much poorer than previously thought. with <IO% surviv- 
ing during 2 years of follow-up. By commst, adults with 
dilated cardiomyopathy have 2 slightly better prognosis. 
with a 23% long-term survival rate (4). Our data in Group 2 
ZTable IB) confirm that children in this older group 111 have 
a poor outcome. Although age of onset wa predictive of 
poor outcome. other factom associated with impending 
death in this group included a positive family history. 
arrhythmi>r and persistent cardiomegaly. 
aped &i&ant ECG abnormalities & ventricular~ectopic 
actwty by Holler monitoring before death. In both younger 
Arrhvlhmias. Patients in both eroucs of this studv devel- 
death. Thus, the development of complex atrial or veotricu- and older age groups. the incidence of sodden death was 
lar arrhythmias was an ominous finding and portended early comparable. Treatmem of atrial or ventricular atrhythm& 
death. The association of arrhythmias with-poor prognosis did not appear to influence outcome, although the number9 
was noted late in the series: extensive Holter data are were small. However. the appearance of atrial fibrillation of 
available on surviving patients. flutter or complex ventricular ectopic activity may be a 
Tkromboembolism was observed in both gronpr. In chnical markerofdeteriorming myocardial function useful in 
Group I. one vatient oresented tvith seizures because of a selecting thox oatients ‘*ho might benefit from cardiac 
sup&d cerebral e&olus. The incidence of thmmboem- transpla&ion. 
b&m with arrhythmias was 5% in Group I and 17% in Endeardial biopsy. Several investigators have suggested 
crolip 2 (5). that improvement of patients with dilated cardiomyopathy 
mav be related to acute or chronic mvocarditis (2.3.1 I .12). 
Discussion 
In view of the increase g utilization of transplantation in 
the treatment of severe cxdiac disease, this study of infants 
and children was undertaken to delineate the outcome of 
patients with dilated cardiomyopathy with current, optimal 
medical mmugement. Our second goal was to identify risk 
factors that would allow early identification of patients with 
a high probability of death within 2 years who would thus be 
appropriate candidates for transplantation. 
Outcome. The prognosis of infants and children with 
dilated cardiomyopathy has varied in previous reports (I-4). 
Among patients with dilated cardiomyopathy who were not 
separated by age of presentation or presumptive diagnosis. 
approximately one-third were in improved condition, one- 
&&d were in stabilized condition and one-thud died (2). Thts 
variable outcome, however, is clarified when patients are 
classified by age of onset and presumptive diagnosis. Among 
patients with dilated cardiomyopathy associated with endo- 
cardial fibroelastosis as diagnosed by angiocardiogmphy (3). 
SO to &I% are cured or improved; 20% have remained stable 
for maw warl with chronic cotwestwe cardiomvooathv: 
H&logic examination of right vent&lar endocardial bi- 
opsy speumen~ in adult patients with dilated cardiomyo. 
pathy has shown an incidence of 5 lo 63% of lymphocytic 
myocardial infiltration suggesting an inllammatory process 
(I 1.12). Some success has been reported in treating these 
patients with cytotoxic immunosuppressive therapy; how- 
ever. these studies are not well contmlled and conlrover~y 
exists concerning the criteria for a histologic diagnosis of 
myocarditis (U-16). Endocardial biopsy of the right and left 
ventricles in children with dilated cardiomyopathy suggests 
that persist&; active myocarditis is an uncommon cause of 
ddated cardiomyopathy in children (17). We have observed 
two deaths in acutely ill children with myocarditis docu- 
mented by autopsy. However, none ofour patients who died 
more than I month after presentation had evidence of 
persistent active inflammation of the myocardium at au- 
topsy. It thus h unlikely that biopsy and immunosuppressive 
therapy will benefit many children with dilated cardiomy 
opathy. For the I7 patients in our series who died, and for 
the 5 others with intractable heart failure, the only potential 
beneficial treatment would have been cardiac transplanta- 
tion. . 
and 20% died. Our results (Table I) agree with these p&i- Trarsplantatioa. Experience with this procedure at Stan- 
ous findint:s. One-fourth of our young patients IGroup I) ford (5) in !48 adults with dilated cardiomyopathy showed a 
with presumed endocardial tibroelastosis died, one-fomth 65% survival ram at I year and a 40 to 50% rate at 5 years. 
had controlled heart failure and one-half improved dramati- These figures are expected lo approach a 66% survival rate 
caliy. Risk factors predictive of pool eatcome in this group at 5 years with more experience and advancements in the 
included persistent cardiomegaly (cardiotboraiic ratto knowledge of immunosuppression (6.7). However. the re- 
>0.70) and the development of ventricular arrhythmia. sobs fmm other institutions are less favorable. with actuarial 
candidales’ for ‘transplantation. Firsf, a11 children over the 
age of 1 years at the lime of onset who survive I month and 
continue 10 have dilated cardiomyopathy should !x imntedi. 
ore/y considered as candidates. Complications that would 
have precluded lransplantslion-sudden death. lhromboem- 
balism and increased pulmonary vascular r&stance-were 
observed within 6 months oi onsel in half of our older 
patients. Among children <2 years old at presentation, the 
selection is more difficult. However. all oalienrs died who 
